Evidence map›Paper›PMID 35798770›Full record

ArticleScientific reports2022

Impact of the temperature on the interactions between common variants of the SARS-CoV-2 receptor binding domain and the human ACE2.

Catherine Forest-Nault, Izel Koyuturk, Jimmy Gaudreault, Alex Pelletier, Denis L'Abbé, Brian Cass, Louis Bisson, Alina Burlacu, Laurence Delafosse, Matthew Stuible and 3 more

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Catherine Forest-Nault *Department of Chemical Engineering, Polytechnique Montreal, Montreal, QC, H3T 1J4, Canada.
Izel Koyuturk *Human Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Jimmy GaudreaultDepartment of Chemical Engineering, Polytechnique Montreal, Montreal, QC, H3T 1J4, Canada.
Alex PelletierHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Denis L'AbbéHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Brian CassHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Louis BissonHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Alina BurlacuHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Laurence DelafosseHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Matthew StuibleHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada.
Olivier HenryDepartment of Chemical Engineering, Polytechnique Montreal, Montreal, QC, H3T 1J4, Canada.
Gregory De CrescenzoDepartment of Chemical Engineering, Polytechnique Montreal, Montreal, QC, H3T 1J4, Canada. gregory.decrescenzo@polymtl.ca.
Yves DurocherHuman Health Therapeutics Research Centre, National Research Council of Canada, Montreal, QC, H4P 2R2, Canada. yves.durocher@cnrc-nrc.gc.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Several key mutations in the Spike protein receptor binding domain (RBD) have been identified to influence its affinity for the human Angiotensin-Converting Enzyme 2 (ACE2). Here, we perform a comparative study of the ACE2 binding to the wild type (Wuhan) RBD and some of its variants: Alpha B.1.1.7, Beta B.1.351, Delta B.1.617.2, Kappa B.1.617.1, B.1.1.7 + L452R and Omicron B.1.1.529. Using a coiled-coil mediated tethering approach of ACE2 in a novel surface plasmon resonance (SPR)-based assay, we measured interactions at different temperatures. Binding experiments at 10 °C enhanced the kinetic dissimilarities between the RBD variants and allowed a proper fit to a Langmuir 1:1 model with high accuracy and reproducibility, thus unraveling subtle differences within RBD mutants and ACE2 glycovariants. Our study emphasizes the importance of SPR-based assay parameters in the acquisition of biologically relevant data and offers a powerful tool to deepen our understanding of the role of the various RBD mutations in ACE2 interaction binding parameters.

Indexed as

Angiotensin-Converting Enzyme 2COVID-19Spike Glycoprotein, CoronavirusTemperatureHumansMutationProtein BindingReproducibility of ResultsSARS-CoV-2ACE2 protein, humanAngiotensin-Converting Enzyme 2Spike Glycoprotein, Coronavirusspike protein, SARS-CoV-2

Identifiers

PMID35798770
PMCPMC9261887

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.